Asston Pharmaceuticals Ltd

Asston Pharmaceu Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Asston Pharmaceuticals Ltd

₹ 68.2 -2.85%
23 Mar 4:02 p.m.
asstonpharmaceuticals.com BSE - SME: 544445
About

Established in 2019, Asston Pharmaceuticals Limited is engaged in the manufacturing and export of pharmaceutical formulations and nutraceutical products under the “Asston” brand.[1]

Key Points

Business Model[1][2]
The company has a diversified model involving:
- Direct manufacturing and marketing of its products
- Contract manufacturing/loan licensing for third-party marketers
- Export sales primarily to African markets

Website BSE
  • Market Cap ₹ 58.0 Cr.
  • Current Price ₹ 68.2
  • High / Low ₹ 126 / 68.0
  • Stock P/E 10.9
  • Book Value ₹ 45.4
  • Dividend Yield 0.00 %
  • ROCE 36.6 %
  • ROE 41.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 48.2%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 358 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE SME IPO

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2024 Mar 2025 Sep 2025
15.97 9.07 15.42
13.71 5.89 13.19
Operating Profit 2.26 3.18 2.23
OPM % 14.15% 35.06% 14.46%
0.64 -0.07 -1.86
Interest 0.42 0.53 0.28
Depreciation 0.02 0.02 0.07
Profit before tax 2.46 2.56 0.02
Tax % 22.76% 23.44% -50.00%
1.90 1.95 0.03
EPS in Rs 24.24 3.11 0.04
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
9.60 6.54 16.03 25.04 24.49
9.96 5.02 12.21 19.60 19.08
Operating Profit -0.36 1.52 3.82 5.44 5.41
OPM % -3.75% 23.24% 23.83% 21.73% 22.09%
0.96 0.65 0.25 0.57 -1.93
Interest 0.43 0.72 0.76 0.95 0.81
Depreciation 0.01 0.04 0.06 0.04 0.09
Profit before tax 0.16 1.41 3.25 5.02 2.58
Tax % 31.25% 25.53% 25.23% 23.11%
0.11 1.06 2.43 3.85 1.98
EPS in Rs 1.57 15.14 31.00 6.14 3.15
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 38%
TTM: 56%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 226%
TTM: 57%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 48%
Last Year: 42%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.70 0.70 0.78 6.27 8.51
Reserves 0.23 1.29 6.40 4.76 30.12
3.31 5.24 6.82 7.25 3.99
5.25 6.46 6.70 9.84 6.86
Total Liabilities 9.49 13.69 20.70 28.12 49.48
0.92 1.13 0.97 0.96 1.33
CWIP 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00
8.57 12.56 19.73 27.16 48.15
Total Assets 9.49 13.69 20.70 28.12 49.48

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-1.19 -0.32 -3.97 -0.03
0.00 -0.91 -0.01 0.73
1.29 1.21 3.86 -0.51
Net Cash Flow 0.10 -0.01 -0.12 0.19

Ratios

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 243.33 480.53 380.71 357.86
Inventory Days 27.24 204.29 53.91 18.59
Days Payable 246.78 754.51 217.50 154.11
Cash Conversion Cycle 23.79 -69.70 217.12 222.34
Working Capital Days -12.17 43.53 162.80 178.86
ROCE % 37.14% 37.78% 36.62%

Insights

In beta
Dec 2019 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 (P)
Total Production Volume
MT

Log in to view insights

Please log in to see hidden values.

Login
Inventory Holding Days
Days
Export Presence (Number of Countries)
Number
Installed Tablet Production Capacity (Unit I)
Crore Tablets/Month
Number of Employees
Number
Capacity Utilization (Tablets)
%
Order Book
USD
Proposed Total Tablet Production Capacity (Unit I + Unit II)
Crore Tablets/Month
Registered Trademarks
Number

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2025
50.66%
6.04%
43.30%
No. of Shareholders 751

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP